Patent Assignment
Reel/Frame 024555/0513
Assignment of Assignor's Interest
Recorded: 2010-06-18
Pages: 6
Assignor
OSI PHARMACEUTICALS, INC.
Executed: 1999-11-30
Assignee
BAYER CORPORATION
511 BENEDICT AVE., TARRYTOWN, NEW YORK, 10591
Covered Properties
(6)
Antibodies Reactive with Normal and Oncogenic Forms of the Ras P21 Protein
Patent:
5,262,523 →
Application:
07/800,052 →
Detection and Quantification of Neu Related Proteins in the Biological Fluids of Humans
Patent:
5,401,638 →
Application:
07/806,112 →
Detection, Quantitation and Classification of Ras Proteins in Body Fluids and Tissues
Patent:
5,443,956 →
Application:
08/078,485 →
Immunoassay for Detection of Mutant P53 Polypeptide in Serum
Patent:
6,083,709 →
Application:
08/094,071 →
Detection of Neu P185 in Cell Lysates
Patent:
5,604,107 →
Application:
08/220,962 →
Detection, Quantitation and Classification of Ras Proteins in Body Fluids and Tissues
Patent:
6,200,764 →
Application:
08/425,885 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 29, 1993
From: REYNOLDS, FREDERICK H., JR.; ZEHEB, RON; STEPHENSON, JOHN R.; SORVILLO, JOHN M.
To: ONCOGENE SCIENCE, INC.
Reel/Frame 006818/0400 →
Merger and Change of Name
Aug 30, 1999
From: ONCOGENE SCIENCE, INC.
To: OSI PHARMACEUTICALS, INC.
Reel/Frame 010197/0519 →
Assignment of Assignor's Interest
Jun 18, 2010
From: BAYER CORPORATION
To: SIEMENS HEALTHCARE DIAGNOSTICS INC.
Reel/Frame 024555/0519 →